Chronic Inflammatory Response Syndrome (CIRS) and the Evidence for Treatment: What a 2024 Review Found

CIRS has become a hot topic for people dealing with persistent symptoms after mold or water damage exposure, but it can be hard to tell what’s actually evidence‑based versus marketing. A 2024 peer‑reviewed review in Frontiers in Medicine, archived on PubMed Central (PMC), took a close look at the existing science on CIRS and its treatments and came to some clear, practical conclusions.

What is CIRS?

The review describes Chronic Inflammatory Response Syndrome (CIRS) as an acquired, multi‑system illness triggered by exposure to biotoxins such as those found in water‑damaged buildings, tick‑borne infections, and certain marine toxins. Instead of acting like a classic allergy, CIRS involves ongoing activation of the innate immune system, with measurable changes in inflammatory markers and regulatory neuropeptides in susceptible individuals.

Patients with CIRS tend to report clusters of symptoms affecting multiple systems at once: fatigue, brain fog, headaches, sinus issues, shortness of breath, temperature dysregulation, gut problems, and more. Genetic factors (often HLA types) may help explain why some people get very sick in the same environment where others feel fine, though this area still needs more research.

How CIRS is Diagnosed in the Research

The paper outlines a structured diagnostic approach that has been used in the CIRS literature, especially by Dr. Ritchie Shoemaker’s group. It typically includes:

• A clear exposure history to a known biotoxin source, especially water‑damaged buildings

• A characteristic symptom pattern across multiple body systems

• Abnormal visual contrast sensitivity (VCS) testing

• A panel of blood markers such as C4a, TGF‑β1, MMP‑9, VEGF, VIP, and MSH

• Sometimes HLA genetic testing to assess susceptibility

This framework comes mostly from one research group and is not yet embedded in mainstream medical guidelines, but within that framework, the authors found consistent patterns: abnormal labs at baseline that move toward normal as patients improve with treatment. That connection between environment, objective findings, and response to treatment is a central theme of the review.

What the Review Found About Treatment

The authors examined all available peer‑reviewed literature they could find that addressed treatment for CIRS and related conditions. Out of 13 CIRS treatment papers they identified, 11 described the same structured approach: the Shoemaker Protocol.

Across those studies (which include double‑blind placebo‑controlled trials, case series, cross‑sectional analyses, and a case–control study), the Shoemaker Protocol was associated with:

• Significant reductions in total symptom scores

• Improvement or normalization of VCS test results

• Shifts in inflammatory markers and hormones toward healthy ranges

• In some work, changes in gene expression and even brain imaging in the direction of recovery

Based on this, the review concludes that the Shoemaker Protocol is currently the only CIRS treatment with published evidence for clinical efficacy, while other frequently mentioned approaches remain largely anecdotal or untested in formal trials.

Where Indoor Air Testing – and InstaScope – Fit In

One of the most practical findings from the review is that continued exposure to water‑damaged buildings can prevent recovery or trigger relapse, even when medical treatment is otherwise on track. That means accurately identifying and confirming indoor environments that are low in problematic particles and spores is a key, real‑world step in supporting patients with CIRS or other biotoxin‑related illnesses.

This is where advanced real‑time airborne particle analysis tools like InstaScope can play a supporting role. While the paper itself focuses on medical evaluation and treatment rather than specific testing technologies, its emphasis on exposure history and building conditions aligns with using high‑resolution, room‑by‑room airborne sampling to:

• Screen for elevated bioaerosol loads in water‑damaged or suspect spaces

• Identify “hot spots” in a home or workplace that may require remediation

• Re‑check spaces after remediation or moisture control work to document that airborne particle levels have improved from a health‑protective standpoint

By giving a quick, quantitative snapshot of indoor bioaerosols, tools such as InstaScope help environmental professionals better characterize the exposure side of the CIRS equation and support clinicians who are trying to match patient symptoms and lab findings with what is actually happening in the building. Used this way, objective indoor air data becomes one part of a larger, collaborative strategy: clinicians manage the medical protocol, and building science practitioners ensure that the environments patients live and work in are as low‑risk as possible for ongoing biotoxin exposure.

Limitations and Why This Matters for Patients

The review is careful about its limitations. Most of the CIRS treatment data come from one investigative group; sample sizes are modest; and there are no large, multi‑center randomized trials yet. The authors therefore call for independent replication, better‑funded research, and broader validation of both diagnostic criteria and treatment steps.

For patients who have been told “your labs are normal” or “mold can’t cause that,” this paper is important because it:

• Recognizes CIRS as an inflammatory, biologically measurable illness in at least a subset of chronically ill patients

• Shows that a structured, evidence‑informed protocol has repeatedly moved both symptoms and lab markers in the right direction

• Underscores the importance of addressing the environment, not just prescribing medications, in people who are sensitive to water‑damaged buildings

When you combine that medical framework with careful building evaluation and modern airborne testing tools, you create a more complete path: identify likely exposure, document and correct indoor air problems, and coordinate with CIRS‑aware clinicians so that medical treatment and environmental control move in the same direction. For many people stuck in chronic, unexplained illness after water‑damage or mold exposure, that integrated approach may be the missing piece that finally connects their symptoms to both the science and their surroundings.